Related Experiment Video
Updated: May 7, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Reduced durability of hybrid immunity to SARS-CoV-2 in immunocompromised children
Youjia Zhong1,2,3, Amuthavalli Kottaiswamy1, Chen Xiang Ang3
1Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore (NUS), Singapore, Singapore.
Insights
Immunocompromised children need a three-dose COVID-19 vaccine primary series for adequate protection. Their immunity wanes faster than in healthy children, requiring frequent booster shots.
Area of Science:
- Immunology
- Vaccinology
- Pediatrics
Background:
- Immunocompromised children face significant risks from endemic COVID-19.
- Optimal primary vaccination and booster schedules for this vulnerable group remain unclear.
Purpose of the Study:
- To evaluate the immunogenicity and durability of hybrid immunity following SARS-CoV-2 vaccination in immunocompromised children.
- To compare vaccine responses in immunocompromised children with those in healthy children.
Main Methods:
- Recruitment of 19 immunocompromised children (transplant recipients, autoimmune disease, leukemia patients).
- Primary vaccination with BNT162b2 mRNA SARS-CoV-2 vaccine.
- Longitudinal follow-up for 1 year post-vaccination, assessing T cell and memory B cell responses.
Main Results:
- Two vaccine doses were insufficient to elicit protective T cell and memory B cell responses in immunocompromised children.
- A third dose significantly enhanced both T cell and memory B cell responses.
- Hybrid immunity declined more rapidly in immunocompromised children, falling below protective levels by 12 months.
Conclusions:
- A three-dose primary vaccination regimen is recommended for immunocompromised children.
- Sustained immunity may necessitate yearly or twice-yearly booster doses in this population.
Background:
In endemic COVID-19, immunocompromised children are vulnerable until vaccinated but the optimal primary vaccination regime and need for booster doses remains uncertain.
Methods:
We recruited 19 immunocompromised children (post-solid organ transplantation, have autoimmune disease or were on current or recent chemotherapy for acute lymphoblastic leukemia), and followed them from the start of primary vaccination with BNT162b2 mRNA SARS-CoV-2 until 1-year post-vaccination. We investigated the quality of vaccine immunogenicity, and longevity of hybrid immunity, in comparison to healthy children.
Results:
Immunocompromised children failed to produce T cell and memory B cell (MBC) responses reaching thresholds of protection after 2 doses; a third dose however improved both responses. Initially robust hybrid immunity demonstrated significantly more decline in T cell and MBC responses in immunocompromised compared to healthy children, to levels below the protective threshold by month 12.
Discussion:
Immunocompromised children may benefit from a 3-dose primary vaccination regime, with yearly or twice-yearly booster doses for sustained immunity.
More Related Videos
08:52Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Humoral Immune Responses
Vaccinations
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...